Literature DB >> 1584214

Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype.

J H Stehle1, S A Rivkees, J J Lee, D R Weaver, J D Deeds, S M Reppert.   

Abstract

A novel adenosine receptor subtype has been cloned from a rat brain cDNA library using a probe generated by the polymerase chain reaction. The cDNA, designated RFL9, encodes a protein of 332 amino acids. The structure of RFL9 is most similar to that of the recently cloned rat A2-adenosine receptor, with a sequence identity of 73% within the presumed seven transmembrane domains. Expression of RFL9 in COS-6M cells resulted in ligand binding and functional activity characteristics of an adenosine receptor that is coupled positively to adenylyl cyclase. Examination of the tissue distribution of RFL9 mRNA by Northern blot analysis showed a restricted distribution with highest levels expressed in large intestine, cecum, and urinary bladder; this pattern was distinct from that of either the A1- or A2-adenosine receptor mRNAs. In situ hybridization studies of RFL9 mRNA showed no specific hybridization pattern in brain, but a hybridization signal was readily observed in the hypophyseal pars tuberalis. Thus, RFL9 encodes a novel A2-adenosine receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584214     DOI: 10.1210/mend.6.3.1584214

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  48 in total

1.  Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.

Authors:  X D Ji; K A Jacobson
Journal:  Drug Des Discov       Date:  1999-11

2.  Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists.

Authors:  I van der Ploeg; S Ahlberg; F E Parkinson; R A Olsson; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

3.  Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.

Authors:  R A Cunha; B Johansson; M D Constantino; A M Sebastião; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

4.  Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73).

Authors:  R Resta; S W Hooker; A B Laurent; S M Jamshedur Rahman; M Franklin; T B Knudsen; N L Nadon; L F Thompson
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

5.  Tissue distribution of adenosine receptor mRNAs in the rat.

Authors:  A K Dixon; A K Gubitz; D J Sirinathsinghji; P J Richardson; T C Freeman
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

6.  A1 adenosine receptors mediate hypoxia-induced ventriculomegaly.

Authors:  Christopher P Turner; Meltem Seli; Laura Ment; William Stewart; Henglin Yan; Bjorn Johansson; Bertil B Fredholm; Michael Blackburn; Scott A Rivkees
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-15       Impact factor: 11.205

7.  Inhibition of platelet aggregation by adenosine receptor agonists.

Authors:  G Cristalli; S Vittori; R D Thompson; W L Padgett; D Shi; J W Daly; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

8.  Coupling of a transfected human brain A1 adenosine receptor in CHO-K1 cells to calcium mobilisation via a pertussis toxin-sensitive mechanism.

Authors:  P A Iredale; S P Alexander; S J Hill
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

9.  A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists.

Authors:  M de Zwart; R Link; J K von Frijtag Drabbe Künzel; G Cristalli; K A Jacobson; A Townsend-Nicholson; A P IJzerman
Journal:  Nucleosides Nucleotides       Date:  1998-06

10.  125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.

Authors:  T M Palmer; S M Poucher; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1995-12       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.